Quick Answer
Actinium Pharmaceuticals, Inc. reported Total Assets of $51.77 million for fiscal year 2025.
Actinium Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $51.77M | -32.7% |
| 2024 | $76.90M | -5.6% |
| 2023 | $81.44M | -28.7% |
| 2022 | $114.19M | +42.1% |
| 2021 | $80.39M | +21.1% |
| 2020 | $66.40M | +469.0% |
| 2019 | $11.67M | -21.6% |
| 2018 | $14.89M | -18.8% |
| 2017 | $18.34M | -18.6% |
| 2016 | $22.53M | -15.3% |
| 2015 | $26.59M | +251.3% |
| 2014 | $7.57M | +31.3% |
| 2013 | $5.77M | -0.4% |
| 2012 | $5.79M | -6.6% |
| 2011 | $6.20M | +4133564.7% |
| 2010 | $150.00 | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $56.15M | -31.6% | -10.9% |
| June 30, 2025 | $63.02M | -29.9% | -8.2% |
| March 31, 2025 | $68.65M | -22.3% | -10.7% |
| December 31, 2024 | $76.90M | -5.6% | -6.4% |
| September 30, 2024 | $82.11M | -7.7% | -8.6% |
| June 30, 2024 | $89.86M | -9.3% | +1.7% |
| March 31, 2024 | $88.35M | -13.4% | +8.5% |
| December 31, 2023 | $81.44M | -28.7% | -8.4% |
- Actinium Pharmaceuticals, Inc. showed a decrease of -32.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Actinium Pharmaceuticals, Inc.’s total assets has grown by 34516566.7% (from $150.00 to $51.77 million).
- The most recent figure is from Actinium Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: